Top Markets
Coin of the day
Theralase Technologies Inc. Theralase Technologies Inc.

Theralase Technologies Inc.

TLT
Pozycja w akcjach #26766
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages... Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Cena akcji
$0.13210864
Kapitalizacja rynkowa
$39.06M
Zmiana (1 dzień)
2.86%
Zmiana (1 rok)
-16.69%
Kraj
CA
Handel Theralase Technologies Inc. (TLT)

Kategoria

Historia ceny akcji dla Theralase Technologies Inc. (TLT)
Najwyższa cena zamknięcia: $0.14 dnia 2026-08-01

Najniższa cena zamknięcia: $0.43 dnia 2008-02-01
Historia cen akcji firmy Theralase Technologies Inc. od 2008 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 54.92%
2025 -37.63%
2024 36.48%
2023 -45.01%
2022 -6.28%
2021 64.88%
2020 -29.76%
2019 -7.60%
2018 21.91%
2017 -3.00%
2016 -24.70%
2015 -39.48%
2014 21.31%
2013 106.96%
2012 -56.21%
2011 -34.50%
2010 56.25%
2009 679.18%
2008 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$114.46 -13.58%
US
$337.66 -13.83%
US
$93.50 0.30%
IE
$50.36 -52.52%
US
$47.28 -15.75%
DE